Technology News and Research

RSS

Computer model shows how cancerous tumors manipulate blood-vessel growth for their own benefit

Rice University researchers have built a simulation to show how cancerous tumors manipulate blood-vessel growth for their own benefit.

9 Jul 2015

Scientists detail how stereomicroscopy can help in assessing issues within gastrointestinal tract

A technology whose roots date to the 1800s has the potential to offer an extraordinary new advantage to modern-day medicine.

9 Jul 2015

Progesterone hormone can benefit breast cancer patients

AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).

9 Jul 2015

Simple blood test could detect early stages of type 1 diabetes

Scientists at the MRC's Clinical Sciences Centre in West London are the first to show that a small molecule circulates in the blood of people who are in the early stages of type 1 diabetes. A simple blood test could detect this biological marker years, maybe decades, before symptoms develop.

9 Jul 2015

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Ludwig Cancer Research and the Cancer Research Institute have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherapies for a variety of solid tumors.

8 Jul 2015

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced the launch of a study that aims to determine utility of the Company's Precision Cancer Monitoring (PCM) technology for predicting response to treatment in advanced melanoma patients receiving one or a combination of the novel immunotherapy agents Yervoy (ipilumumab), a CTLA-4 inhibitor, and Opdivo (nivolumab), a PD-1 inhibitor.

8 Jul 2015

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.

8 Jul 2015

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

Smith & Nephew plc, the global medical technology business, today announces a partnership with ScopisGmbH, the German developer and manufacturer of surgical navigation systems, as the exclusive distributor of Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium from 1 July.

8 Jul 2015

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study demonstrated that its single-use autologous cell suspension technology ReCell was safe and effective in skin repigmentation for patients suffering with depigmented skin lesions caused by vitiligo and piebaldism.

8 Jul 2015

UNICEF takes step to improve access to assistive products for children with disabilities

In a unified push to make assistive products for children with disabilities more available, affordable and appropriate, the United Nations Children’s Fund was joined by governments, partners, leading disability advocates and NGOs at the first-ever forum to examine the global supply gap and identify ways to reverse longstanding deficiencies.

8 Jul 2015

Chromosomal abnormalities in embryos created for IVF can be predicted at earliest stage of human development

Scientists at Oregon Health & Science University, Stanford University, University of Valencia and IGENOMIX have discovered that chromosomal abnormalities in human embryos created for in vitro fertilization, or IVF, can be predicted within the first 30 hours of development at the cell-1 stage which results from the union of a female egg and male sperm.

8 Jul 2015

MU scientists develop RNAMiner tool to make genetic science easier

Technology rapidly is advancing the study of genetics and the search for causes of major diseases. Analysis of genomic sequences that once took days or months now can be performed in a matter of hours. Yet, for most genetic scientists, the lack of access to computer servers and programs capable of quickly handling vast amounts of data can hinder genetic advancements.

8 Jul 2015

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine has developed a novel approach that dramatically simplifies the evaluation of the liver's drug-metabolizing activity and the potential toxic effects of the products of that activity on other organs.

8 Jul 2015

Guidelines on children's exposure to radio frequency electromagnetic fields confusing for parents

New research suggests guidelines on children's exposure to radio frequency waves from technology are confusing for parents.

8 Jul 2015

New upright microscopes with LED and 19 mm FOV

Leica Microsystems launches the upright microscopes Leica DM4 B and Leica DM6 B for life science research and clinical applications.

From Leica Microsystems GmbH 7 Jul 2015

New public guide addresses unrealistic expectations of screening tests

Misconceptions about how screening works, its limitations and possible harms are still being perpetuated by media stories and high profile cases, such as Angelina Jolie's double mastectomy and emotive tabloid case studies of women under 25 dying from cervical cancer.

7 Jul 2015

EnteroMedics prices previously announced public offering of 32,000,000 units

EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 32,000,000 units.

7 Jul 2015

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.

7 Jul 2015

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.

7 Jul 2015

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

For every life saved by Norway's Breast Cancer Screening Programme, five women are over-diagnosed, and have to go through an operation to remove a tumour that otherwise never would have caused problems.

7 Jul 2015

Technology News and Research

Computer model shows how cancerous tumors manipulate blood-vessel growth for their own benefit

Scientists detail how stereomicroscopy can help in assessing issues within gastrointestinal tract

Progesterone hormone can benefit breast cancer patients

Simple blood test could detect early stages of type 1 diabetes

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

UNICEF takes step to improve access to assistive products for children with disabilities

Chromosomal abnormalities in embryos created for IVF can be predicted at earliest stage of human development

MU scientists develop RNAMiner tool to make genetic science easier

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

Guidelines on children's exposure to radio frequency electromagnetic fields confusing for parents

New upright microscopes with LED and 19 mm FOV

New public guide addresses unrealistic expectations of screening tests

EnteroMedics prices previously announced public offering of 32,000,000 units

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News